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Background: Prostate cancer is for many men a chronic disease with a long life expectancy after treatment. The impact of prostate
cancer therapy on men has been well defined, however, explanation of the consequences of cancer treatment has not been
modelled against the wider variables of long-term health-care provision. The aim of this study was to explore the parameters of
unmet supportive care needs in men with prostate cancer in relation to the experience of nursing care.
Methods: A survey was conducted among a volunteer sample of 1001 men with prostate cancer living in seven European countries.
Results: At the time of the survey, 81% of the men had some unmet supportive care needs including psychological, sexual and
health system and information needs. Logistic regression indicated that lack of post-treatment nursing care significantly predicted
unmet need. Critically, men’s contact with nurses and/or receipt of advice and support from nurses, for several different aspects of
nursing care significantly had an impact on men’s outcomes.
Conclusion: Unmet need is related not only to disease and treatment factors but is also associated with the supportive care men
received. Imperative to improving men’s treatment outcomes is to also consider the access to nursing and the components of
supportive care provided, especially after therapy.
Prostate cancer is a significant health burden within Europe with
recent survival data suggesting that the number of men with this
disease will increase over the next 20 years (Berrino et al, 2007;
Siegel et al, 2012). Prostate cancer is being detected earlier, and as a
consequence more men receive treatment and subsequently face
adverse effects of therapy (Resnick et al, 2013b). Despite
improvements to cancer treatment, some men will continue to
experience long-term consequences. Population-based studies have
highlighted that prostate cancer survivors report significant
chronic illness compared with age-matched controls, with poorer
health status and reduced quality-of-life (Van Hemelrijck et al,
2010; Elliott et al, 2011; Khan et al, 2011; Higano, 2012; Lustberg
et al, 2012). Increasingly, there is recognition that lifestyle
factors correlate with the risk of late pelvic symptoms
after prostate cancer treatment (Thomas et al, 2013) and can have
an impact on men’s overall survival (Kenfield et al, 2011).
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Such survivorship results in an enduring requirement for health-
care monitoring and challenges providers of cancer care to
effectively respond to men’s long-term supportive care needs
(Simonelli et al, 2008; Harrison et al, 2009; McCabe et al, 2011).
Critical to health service planning is the need to recognise
the factors that contribute to men’s poorer health and the ability to
identify what supportive care packages, such as nursing, are needed
and at what time in the treatment and recovery pathway.
Although studies of prostate cancer often focus on functional
outcomes of therapy, the extent to which adverse effects bother
men also needs careful evaluation (Luckett et al, 2009; Pachman
et al, 2012; Seklehner et al, 2012). Understanding the importance of
comprehensive patient outcomes is essential in delivering whole-
patient cancer care (Jacobsen et al, 2012; Stanton, 2012). Studies
exploring unmet needs of men with prostate cancer consistently
show that these needs are highest in relation to psychological
and sexuality issues, as well as information about treatment and
care in the health-care setting (Steginga et al, 2001; Boberg et al,
2003; White et al, 2012). Several predictive analyses from unmet
needs studies have found significant associations between unmet
need and factors of age, education, marital status, treatment
variables, disease characteristics and mental affect (Smith et al,
2007; Ream et al, 2008). None of these studies have explored
unmet need against the type or nature of supportive care these men
received. Identifying the characteristics of unmet need and nursing
outcomes over the cancer pathway can contribute to the evidence
of the impact of specialist nurses as well as clarify quality
parameters in providing good after-care. In this study, we examine
the relative predictive impact of prostate-specific dimensions of
nursing care on the scope and extent of men’s unmet supportive
care needs across seven countries within Europe.
MATERIALS AND METHODS
We surveyed men with a diagnosis of prostate cancer living in
Denmark, France, Ireland, Netherlands, Spain, Turkey and the UK
via on-line and paper questionnaire. Pre-survey information,
together with the on-line link, was posted on support group,
charity and nursing organisation websites, and leaflets were
distributed through support networks and clinic settings. The
questionnaire was translated and the response was anonymous.
The survey was available on-line for one month in October/
November 2011 during which time 1131 eligible men started the
questionnaire and 558 (49%) completed. Between October 2011
and early January 2012, 2111 paper questionnaires were also made
available to centres for use where paper completion was preferred
(numbers of questionnaires distributed within the individual
countries were not recorded). A total of 443 (21%) completed
paper questionnaires were returned to the United Kingdom.
Consent information was given within the survey before the start
of both on-line and paper questionnaire and consent was indicated
by commencement of the survey.
Three patient-reported outcome scales were included in the
questionnaire.
The Supportive Care Needs Survey (SCNS) is a valid and
reliable 34-item tool for assessing cancer patients’ unmet needs.
It assesses five domains: psychological; sexuality; health system and
information; physical and daily activity and patient care and
support (Boyes et al, 2009). Need for help is rated on a five-point
scale: 1¼ not applicable, 2¼ satisfied, 3¼ low need, 4¼moderate
need and 5¼ severe need. Five items from the SCNS prostate-
specific module were also used related to urinary function, bowel
function and hormonal effects.
The EuroQol EQ-5D-3L is a standardised, valid and reliable
measure of health status for clinical and economic use (Pickard
et al, 2007). It measures five dimensions: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression. Each is
scored on a three-point scale representing no problem, some
problem and extreme problem. A self-rating scale of Health State is
scored from 0–100 on a visual scale, 0 representing the ‘worst
imaginable health state’ and 100 representing the ‘best imaginable
health state’.
Experience of supportive nursing care was measured using a
scale developed by the authors. It contained nine dimensions
of supportive care commonly provided by hospital nurses
(see column 1 in Table 4). The items were developed based on
research literature utilising evidence from specialist nursing
domains (Eicher et al, 2012) and clinician and patient consultation
in each of the seven countries. Response was measured on a four-
point scale by participants indicating for each dimension if they
strongly agreed, agreed, disagreed or strongly disagreed that they
had received advice and support. If they had not seen a nurse at all
for that dimension of care, they were asked to check a fifth column.
These questions aimed to provide patient-reported data for nursing
provision and covered supportive care across the disease journey.
We also collected demographic characteristics (age, education,
living status, ethnicity and country of residence), and disease and
treatment characteristics (time since diagnosis, treatment modality,
time since treatment, time last assessed by a clinician and stage of
disease).
We hypothesised that demographic and treatment character-
istics, patient-reported outcomes of quality-of-life (mental affect
and health state) and patient experience would be associated with
unmet needs of men with prostate cancer. Descriptive analysis
examined sample characteristics and patient-reported outcome
measures. Analysis for SCNS domains was conducted on an overall
response of no need (all item responses of not applicable or
satisfied) vs some need (at least one item response of low, moderate
or high unmet need). Within each domain, missing item responses
were imputed using multiple imputations (Markov Chain Monte
Carlow method) in IBM SPSS Statistics version 19.0 (London, UK).
Predictive modelling for some need was developed using the
backwards elimination selection procedure to identify suitable
logistic regression models for each of the five domains based on the
pooled model results. Where possible, interactions were included
in the models but none were found to be significant. All testing was
conducted at the 5% significance level. Covariates incorporated
into the models included known predictors of need from other
published studies: age, country of residence, education, living
status, stage of disease, time since diagnosis, time since last
assessed, treatment modality, treatment status nested within
treatment degree, mental affect (measured by the EuroQol item
on depression and anxiety) and health state (Table 1). Nine
variables relating to supportive nursing care across the disease
journey were introduced to the final analysis to assess whether
men’s experience of nursing care could explain any variation over
and above that explained by the initial models. Backwards
elimination was used to remove non-significant terms. The
resulting final models were all statistically significant Po0.001
for all domains. The Youden indices ranged from 0.316 to 0.564.
Sensitivity and specificity were higher comparing the models with
nursing care variables to the initial models for the psychological,
health system and information and the patient care and support
domains.
RESULTS
Study participants. Data was based on 1001 complete question-
naires. The majority of participants were aged between 61–80, of
white ethnic origin and living with others, and there were similar
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numbers of men in each of the education categories (Table 2). Over
one-quarter of the sample had been diagnosed within the last year,
and one-quarter 1 and 2 years previously. A total of 36.9% of men
were receiving treatment at the time of the survey, 20.5% were o1
year out of treatment and 40.4% wereX1 year out of treatment; few
were considering treatment. Equal numbers of men had received
radical prostatectomy, radiotherapy or hormone therapy (43.6%/
44.6%/43.8%), fewer men had experience of active surveillance (16.2%)
and watchful waiting (12.2%), 57.7% of men had received multiple
treatments. Moderate or extreme anxiety or depression (mental affect)
was reported by 33.7% of men: normative data are only available in
three countries (Netherlands, Spain and the United Kingdom)
indicating percentage ranges for men over 40 years of age to be 18–
33%, 7–20% and 16–26%, respectively (Svende and Williams, 2004)
and mental affect measured by the EQ-5D for men with prostate
cancer in the United Kingdom has been reported at 30% (Ream et al,
2008). Mean self-rating for health state was 74.3 (s.d. 17.6 median 80,
65/90) (Table 2): normative data for men in Netherlands, Spain and
the United Kingdom indicate mean ranges across age groups for men
over 40 years of age to be 69–82, 67–78 and 71–85, respectively.
Prevalence of unmet supportive care needs. More than 80% of
men in the sample had some unmet need across the five domains
measured; psychological needs, sexuality needs, and health system
and information needs had the greatest prevalence (Table 3).
Prostate-specific symptoms were reported by over half the
participants: incontinence or dysuria was the most prevalent,
followed by hormonal symptoms and then bowel problems
(Table 3). Over 45% of men indicated that they had not seen a
nurse at all for one or more dimensions of care during their
pathway (Table 4). When men had seen a nurse, support and
advice was highest in pre-treatment and immediate treatment-
related care: over 80% had received advice and support for
screening, diagnosis, side effects and treatment after-care. How-
ever, fewer men reported advice and support for longer-term
effects, home care, choosing treatment options, referral and
emotional support (Table 4).
Predictors of unmet supportive care need. Dimensions of post-
treatment nursing care significantly and independently predicted
unmet need. The most common aspect was for longer-term effects:
men who had not seen a nurse about longer-term effects were twice
as likely to have health system and information needs and patient
care and support needs. Similarly, men who had not received
advice and support from a nurse for longer-term effects were three
times as likely to have health system and information needs and
patient care and support needs. In addition, men who had not
received advice about longer-term effects were twice as likely to
have psychological need (Table 5).
Three further areas were significantly associated with unmet
need: not seeing a nurse for treatment side effects was associated
with psychological need, lack of advice and support for after-care
was associated with patient care and support need, and lack of
advice and support for home care was associated with sexuality and
health system and information need. Nursing care did not predict
need in the physical and daily living domain (Table 5). A number
of further factors had an impact on unmet needs. The country a
man lived in, the stage of his disease and the type of treatment he
had experienced were the most common demographic and
treatment predictors of unmet need (Table 5). Men in Spain were
more likely to have psychological and health system and
information needs, and together with men in France, they had a
higher probability of sexuality-related needs than men in Denmark
(reference category). Men with more extensive disease were more
likely to have psychological and health system and information
needs and to require help with patient care and support issues.
Treatment modality was a significant predictor of unmet need in
three respects. Having had chemotherapy was strongly predictive
of unmet physical and daily living needs, and having had radical
prostatectomy was predictive of unmet sexuality need, whereas
men who had had radiotherapy were less likely to have
psychological need than men who had not (Table 5).
Men who had finished treatment 1 or more years ago were
significantly less likely to have physical and daily living needs
compared with men on treatment. The more recently a man had
been assessed by a clinician the more likely he was to have health
system and information needs, although this was not influenced by
time since diagnosis. Conversely, men diagnosed 1–2 months ago
were ten times more likely to need help with sexuality issues than
men at diagnosis (within the last month) and this changed over
time. Neither age nor education nor living status was found to be a
significant predictor of unmet need in any domain having included
the nursing care variables.
Patient-reported parameters of mental affect and health state
were each associated with unmet need for all domains (Table 5).
Increasing health state by one unit produced an estimated decrease
in odds of reporting need ranging between 1.7 and 4.2% across
domains. Men with moderate or severe anxiety or depression were
approximately twice as likely to have sexuality, health system and
information, patient care and support or physical and daily living
needs, but in line with previous studies, this association was greatly
increased in relation to psychological need (odds ratio¼ 7.604).
The questionnaire format was significantly associated with unmet
need: men who completed the survey in paper format were less
likely than men who had completed it on-line to have unmet
psychological physical and daily living needs (Table 5).
DISCUSSION
This study makes an important contribution to the understanding
of the role of supportive care in addressing survivorship needs for
men with prostate cancer and the significance of nursing in
reducing men’s unmet needs. In addition to disease and treatment
characteristics, lack of contact with a nurse or advice and support
from a nurse was associated with men’s unmet needs. The greatest
areas of need reflect other survey data (Boberg et al, 2003;
Feldman-Stewart et al, 2010; Harrison et al, 2011), which suggest
that current services may not be addressing on-going concerns that
have an impact on men’s long-term distress (Foster et al, 2009;
Davies and Batehup, 2011). This provides evidence that access to
supportive nursing care can influence patient outcomes, and
importantly indicates that there are areas of care, in particular after
cancer treatment, that nursing could improve.
Table 1. Derived variables
Variable Definition
Treatment
modality
Created for all separate treatments received, defined as
not had treatment vs received/currently receiving
treatment
Treatment
degree
Considering treatment or monitoring vs had a single
treatment modality vs had multiple treatment modalities
Treatment
status
Considering treatment or monitoring vs currently
on-treatment vs finished treatment o1 year ago vs
finished treatment more than1 year ago
Mental affect Derived from the EuroQoL EQ-5D anxiety/depression
dimension, where a response of not anxious or
depressed¼ 0 and moderately or extremely
depressed¼ 1
Health state A continuous variable represented by participant
rating on the EuroQoL EQ-5D VAS scale
The impact of supportive nursing care in prostate cancer BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2013.568 2123
Relatively few studies have hitherto researched how supportive
nursing intervention can have an impact on men’s outcomes after
prostate cancer treatment (Ream et al, 2009; Cockle-Hearne
and Faithfull, 2010; Chambers et al, 2011; Faithfull et al, 2011;
Sussman et al, 2011). Systematic reviews on efficacy of specialised
oncology nursing interventions offer evidence that nurse provision
leads to improvements in the management of chronic problems
and increases patient knowledge and self-management; it can also
lead to reduced use of acute services and improve patient
symptoms (Corner, 2003; Sussman et al, 2004). Subsequently,
nurse-led care and coordination roles have been promoted as an
important component of breast cancer services (Eicher et al, 2012)
and have been embraced by cancer teams as part of quality care
provision (Roselli Del Turco et al, 2010). Strong evidence that the
provision of breast cancer clinical nurse specialists has a
psychological impact on women has come from randomised trials
both during and after treatment. These studies indicate that nurse
Table 2. Sample characteristics
Base 1001 %
Country response
The Netherlands 319 31.9
UK 180 18.0
Spain 179 17.9
Denmark 125 12.5
France 95 9.5
Ireland 53 5.3
Turkey 50 5.0
Questionnaire format
On-line 558 55.7
Paper 443 44.3
Age
50 or less 17 1.7
51–60 142 14.2
61–70 531 53.0
71–80 279 27.9
81 þ 31 3.1
Totala 1000
Education
Finished before 18 without qualifications 271 27.3
Finished at 18 with qualifications 274 27.6
Gained a diploma/certificate after 18 207 20.8
Gained a degree (bachelor’s, master’s or doctorate) 240 24.1
Totala 992
Living status
Living with other (s) 907 90.6
Living alone 94 9.4
Ethnic origin
White 975 98.0
Black - Caribbean 2 0.2
Black - African 1 0.1
Mixed ethnic origin 1 0.1
Other ethnic group 4 0.4
Prefer not to say 12 1.2
Totala 995
Time since diagnosis
Within the last month 24 2.4
1–2 month ago 20 2.0
3–6 months ago 92 9.2
7–12 months ago 120 12.0
1–2 years ago 246 24.6
3–4 years ago 189 18.9
5–10 years ago 237 23.7
More than 10 years ago 70 7.0
Totala 998
Stage of prostate cancer
Stage I 112 16.4
Stage II 112 16.4
Stage III 93 13.6
Stage IV 63 9.2
Don’t know/can’t remember 305 44.5
Totala 685
Table 2. ( Continued )
Base 1001 %
Treatment modalityb
Received/currently receiving
Prostatectomy 436 43.6
Radiotherapy 446 44.6
Brachytherapy 99 9.9
Hormone therapy 438 43.8
Chemotherapy 101 10.1
High-intensity ultrasound 16 1.6
Active surveillance 162 16.2
Watchful waiting 122 12.2
Treatment degree
Considering treatment or monitoring 22 2.2
Had a single treatment modality 398 40.1
Had multiple treatment modalities 573 57.7
Totala 993
Treatment status
Considering treatment or monitoring 22 2.2
On treatment 366 36.9
Finished treatment up to 1 year ago 204 20.5
Finished treatment 1 or more years ago 401 40.4
Totala 993
Last assessed by clinician
Within the last year 657 66.8
One year ago 93 9.5
2 years ago 64 6.5
3 years ago 40 4.1
4–13 years ago 130 13.1
Totala 984
Health state (rating 0–100)
Rated under 50 76 8.0
Rated 50–74 319 33.6
Rated 75–100 554 58.4
Totala 949
Anxiety/depression (mental affect)
Not anxious or depressed 635 66.3
Moderately or extremely depressed 323 33.7
Totala 958
aTotal excludes missing data.
bParticipants may have had more than one treatment.
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intervention reduces anxiety (Wengstrom et al, 2001; Yates et al,
2005), distress and depression (Strong et al, 2008; Fors et al, 2011)
and increases satisfaction in women compared with usual care
(Aranda et al, 2006; Beaver et al, 2012). However, in a randomised
trial of specialist nursing support for women compared with that
provided by a psychologist there were no significant differences in
outcome (Arving et al, 2006). This would suggest that it is the
quality of contact and/or the intervention targeted against the
need, rather than necessarily the role, that has an impact on patient
experience. Such a targeted intervention model has been evaluated
in Canada with specialist community nurses providing care
coordination: this led to a marked improvement in patients’
unmet supportive care needs (Sussman et al, 2011). Defining the
individual dimensions of supportive care required by men in this
present study has provided potential targets for cancer nursing
intervention within Europe. Fundamental to this is a comprehen-
sive understanding of patient-specific need as an essential
precursor to appropriate interventions and for facilitating access
to relevant supportive care services as well as training staff to meet
those needs (Stricker et al, 2011; Chubak et al, 2012).
It is clear that treatment factors remain important predictors of
patient outcome. Men in this study reported higher levels of unmet
need in relation to specific treatment modalities, including
chemotherapy, which was strongly predictive of need for help
with physical and daily living issues, and radical prostatectomy,
which was predictive of unmet sexuality needs. Men, who had had
radiotherapy, were less likely to have psychological need than men
who had not. These unmet needs are consistent with recent
prospective clinical studies comparing radiotherapy and prosta-
tectomy; men who underwent radical prostatectomy were five
times more likely to have urinary incontinence and twice as likely
to have erectile dysfunction at 5 years than those men in the
radiotherapy group (Resnick et al, 2013b). Late effects from
prostate cancer treatment are often time-dependent and men’s
lifestyle and co-morbidity can have an impact on rectal, urinary
and erectile dysfunction (Thomas et al, 2013). Sexual dysfunction
is common in the older population and co-morbidities have an
impact on the complexity of predicting erectile problems post
treatment (Nelson et al, 2010). It is therefore important to
have discussions with men about prevention and possible
management of erectile dysfunction before and after therapy
(Salonia et al, 2012).
The potential weakness of this study was that it was a ‘snap shot’
in time of symptoms and unmet needs; it was therefore not
possible to differentiate co-morbidities from those of prostate
treatment effects. We did not find a relationship between age,
education or living status and unmet need, which has been found
Table 3. Prevalence of unmet need
No need Some need
N¼1001 n
% of
total n
% of
total
Total need 186 18.6 771 80.6
Supportive care need domains
Psychological 325 34.9 607 65.1
Sexuality 377 39.7 573 60.3
Health systems and information 380 40.3 563 59.7
Physical and daily living 559 59.0 388 41.0
Patient care and support 566 59.3 389 40.7
Prostate-specific symptoms
Urinary incontinence/difficulties in
passing urine
583 60.5 380 39.5
Hot flushes/feeling as if you are going
through a change of life like women do
644 66.3 327 33.7
Problems with your bowel habits 710 73.6 255 26.4
Totals exclude missing data
Table 4. Dimensions of supportive nursing care
Did not see a nurse at all
When a nurse was seen support and
advice received
Total 1001 % 1001 %
Advice about screening Did not see a nurse 421 45.2 Had support 426 83.5
Totala 931 Totalb 510
Information and support at the time of diagnosis Did not see a nurse 303 33.0 Had support 515 83.6
Totala 919 Totalb 616
Help choosing treatment options Did not see a nurse 415 46.3 Had support 320 66.4
Totala 897 Totalb 482
Provided enough immediate care after treatment Did not see a nurse 198 20.6 Had support 683 89.4
Totala 962 Totalb 764
Information and advice about side effects that occur after treatment Did not see a nurse 284 30.4 Had support 524 80.5
Totala 935 Totalb 651
Information, advice and support about longer-term side effects Did not see a nurse 432 46.7 Had support 307 62.1
Totala 926 Totalb 494
Gave emotional support to me and/or my family and friends Did not see a nurse 378 39.5 Had support 436 69.6
Totala 956 Totalb 626
Referral to other services Did not see a nurse 533 56.0 Had support 239 57.0
Totala 952 Totalb 419
Advice about home care Did not see a nurse 523 54.7 Had support 286 66.1
Totala 956 Totalb 433
aAll participants who responded to question.
bAll participants who indicated they had seen a nurse for that aspect of care.
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Table 5. Predictors of unmet supportive care needs
Domain Predictor Estimatea
Standard
errora P-valuea
Odds ratioa (95%
confidence interval)
Psychological Country (reference: Denmark)    
France 0.377 0.649 0.561 0.686 (0.192, 2.447)
Ireland 0.701 0.614 0.253 2.016 (0.605, 6.716)
The Netherlands 0.006 0.484 0.990 1.006 (0.390, 2.598)
Spain 1.539 0.446 0.001 4.658 (1.942, 11.170)
Turkey 0.426 0.675 0.528 1.531 (0.407, 5.751)
UK 0.390 0.533 0.464 0.677 (0.238, 1.923)
Stage (reference: Stage I)    
Stage 2 1.166 0.364 0.001 3.209 (1.573, 6.548)
Stage 3 1.095 0.404 0.007 2.988 (1.353, 6.599)
Stage 4 1.168 0.497 0.019 3.216 (1.214, 8.515)
Do not know; cannot remember 0.785 0.309 0.011 2.192 (1.196, 4.019)
Receiving/received radiotherapy(reference: not had) 0.471 0.232 0.043 0.625 (0.396, 0.985)
Mental affect (reference: not anxious or depressed)    
Moderately/extremely anxious or depressed 2.029 0.323 o0.001 7.604 (4.037, 14.325)
Health state 0.040 0.008 o0.001 0.961 (0.945, 0.976)
Nursing care (reference: had advice and support)    
No nurse advice for treatment side effects 0.124 0.366 0.735 1.132 (0.553, 2.319)
No nurse contact for treatment side effects 0.912 0.315 0.004 2.490 (1.343, 4.616)
No nurse advice for longer-term effects 0.747 0.344 0.030 2.111 (1.076, 4.144)
No nurse contact for longer-term effects 0.050 0.293 0.865 0.951 (0.536, 1.690)
Paper format (reference: on-line) 0.914 0.379 0.016 0.401 (0.191, 0.842)
Sexuality Country (reference: Denmark)    
France 0.748 0.355 0.035 2.112 (1.053, 4.235)
Ireland 0.093 0.375 0.803 1.098 (0.526, 2.291)
The Netherlands 0.070 0.243 0.774 0.933 (0.579, 1.502)
Spain 1.144 0.307 o0.001 3.138 (1.720, 5.727)
Turkey 0.330 0.457 0.470 1.391 (0.568, 3.406)
UK 0.328 0.260 0.208 0.720 (0.432, 1.200)
Time since diagnosis (reference: within last month)    
1–2 months 2.322 0.960 0.016 10.199 (1.553, 66.955)
3–6 months 0.974 0.618 0.115 2.649 (0.788, 8.901)
7–12 months 1.028 0.602 0.088 2.796 (0.857, 9.127)
1–2 years 0.782 0.585 0.182 2.186 (0.693, 6.897)
3–4 years 0.802 0.589 0.174 2.230 (0.702, 7.085)
5–10 years 0.625 0.581 0.282 1.869 (0.597, 5.850)
More than 10 years 0.686 0.624 0.272 1.986 (0.583, 6.758)
Receiving/received prostatectomy (reference: not had) 0.453 0.160 0.005 1.573 (1.150, 2.153)
Mental affect (reference: not anxious or depressed)    
Moderately/extremely anxious or depressed 0.560 0.183 0.002 1.751 (1.225, 2.505)
Health state 0.022 0.005 o0.001 0.978 (0.969, 0.988)
Nursing care (reference: had advice and support)    
No nurse advice about home care 0.734 0.260 0.005 2.083 (1.252, 3.466)
No nurse contact about home care 0.105 0.187 0.574 1.111 (0.770, 1.605)
Patient care and support Stage (reference: Stage I)    
Stage 2 0.691 0.335 0.039 1.997 (1.035, 3.850)
Stage 3 0.502 0.357 0.160 1.652 (0.820, 3.329)
Stage 4 0.663 0.406 0.103 1.940 (0.875, 4.303)
Do not know/cannot remember 0.485 0.284 0.088 1.624 (0.930, 2.836)
Mental affect (reference: not anxious or depressed)    
Moderately/extremely anxious or depressed 1.038 0.220 o0.001 2.823 (1.833, 4.348)
Health state 0.019 0.006 0.002 0.981 (0.969, 0.993)
Nursing care (reference: had advice and support)    
No nurse advice for after-care 1.614 0.395 o0.001 5.020 (2.316, 10.882)
No nurse contact for after-care 0.153 0.263 0.560 1.166 (0.696, 1.953)
No nurse advice for longer-term effects 0.995 0.278 o0.001 2.706 (1.570, 4.664)
No nurse contact for longer-term effects 0.571 0.234 0.015 1.770 (1.119, 2.800)
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in other studies (Steginga et al, 2001; Lintz et al, 2003; Smith et al,
2007; Ream et al, 2008). However, living in Spain was associated
with a higher probability of unmet sexuality, psychological and
health system and information need, and living in France was also
associated with a higher probability of unmet sexuality need. This
may be the result of differing cultural expectations in relation to
sexual attitudes in these two countries. Men with cancer are less
likely than women to recognise the need for help because of
cultural and societal barriers especially in relation to sexual issues
(Courtenay, 2000; Tamres et al, 2002; Hautamaki-Lamminen et al,
2013). It should also be emphasised that the association of unmet
need with the country of residence in this study was independent
of the effect of supportive nursing care as measured.
An important theme emerging from the analysis was the lack of
support for on-going symptoms and concerns after treatment and
their association with unmet need. Evidence from a recent patient-
reported outcome study within the United Kingdom (DoH, 2012)
suggested information and preparation for cancer follow-up is
limited. Patients described being ‘cut adrift’ by the health system
after active therapy (Corner et al, 2013). Patient satisfaction with
health-care provision is an important measure in assessing the
structure and process of cancer care, and is associated with reduced
quality-of-life including decline in post-treatment physical
function (Resnick et al, 2013a). In this present study, recent
assessment by a clinician and being a year or more out of treatment
were significant predictors of unmet need, indicating that clinician
contact paradoxically did not always address men’s needs. This is
also confirmed in a longitudinal study of patients after cancer
treatment, despite follow-up checks over 30% of patients, who had
symptoms at the end of therapy, continued to experience such
symptoms 12 months later (Armes et al, 2009). Providing long-
term care for prostate cancer patients has been reported as
challenging especially in primary care (Zhou et al, 2010). In the
United States of America, studies have shown that only a minority
of physicians feel able to manage the consequences of cancer
treatment (McCabe et al, 2011; Skolarus et al, 2011; Chubak et al,
2012). Oncologists in the UK have also shown concern
that primary care doctors have little experience of follow-up
and longer-term effects of prostate cancer treatment (Watson
et al, 2011). The predictive model in this study shows that unmet
need can change over time in that men were much more likely to
need help with sexuality issues when they had been recently
diagnosed; however, as stage of disease progressed, unmet
psychological, patient care and information needs remained.
Table 5. ( Continued )
Domain Predictor Estimatea
Standard
errora P-valuea
Odds ratioa (95%
confidence interval)
Health system and information Country (reference: Denmark)    
France 0.421 0.479 0.380 1.523 (0.595, 3.898)
Ireland 0.380 0.540 0.481 0.684 (0.237, 1.970)
The Netherlands 0.153 0.362 0.672 0.858 (0.422, 1.744)
Spain 1.325 0.448 0.003 3.764 (1.563, 9.067)
Turkey 0.483 0.627 0.441 1.621 (0.474, 5.542)
UK 0.071 0.386 0.854 1.074 (0.503, 2.289)
Stage (reference: Stage I)    
Stage 2 0.788 0.334 0.018 2.199 (1.142, 4.236)
Stage 3 1.220 0.369 0.001 3.389 (1.645, 6.979)
Stage 4 1.169 0.451 0.010 3.219 (1.330, 7.791)
Do not know/cannot remember 0.734 0.280 0.009 2.083 (1.203, 3.607)
Time since last assessed 0.130 0.044 0.004 0.878 (0.805, 0.958)
Mental affect (reference: not anxious or depressed)    
Moderately/extremely anxious or depressed 1.000 0.253 o0.001 2.718 (1.654, 4.465)
Health state 0.017 0.007 0.012 0.983 (0.970, 0.996)
Nursing care (reference: had advice and support)    
No nurse advice for longer-term effects 1.264 0.318 o0.001 3.539 (1.899, 6.596)
No nurse contact for longer-term effects 0.937 0.255 o0.001 2.553 (1.549, 4.205)
No nurse advice about home care 1.018 0.354 0.004 2.769 (1.383, 5.544)
No nurse contact about home care 0.130 0.259 0.615 1.139 (0.686, 1.892)
Physical and daily living Receiving/received chemotherapy (reference: not had) 1.716 0.316 o0.001 5.561 (2.995, 10.324)
Treatment status (reference: on treatment)    
Finished treatment up to 1 year ago 0.260 0.215 0.226 1.296 (0.851, 1.974)
Finished treatment 1 or more years agob 0.489 0.185 0.008 0.613 (0.427, 0.881)
Mental affect (reference: had advice and support)    
Moderately/extremely anxious or depressed 0.866 0.170 o0.001 2.377 (1.704, 3.315)
Health state 0.043 0.005 o0.001 0.958 (0.948, 0.968)
Paper format (reference: on-line) 0.489 0.165 0.003 0.614 (0.444, 0.848)
Based on observed data: psychological domain specificity 57.9%, sensitivity 85.7% Youden index 0.436; sexuality domain specificity 51.6% sensitivity 78.2% Youden index 0.564; health system
and information domain specificity 55.0% sensitivity 82.5% Youden index 0.375; patient care and support domain specificity 81.4% sensitivity 50.2% Youden index 0.316; physical and daily living
domain specificity 84.1% sensitivity 58.4% Youden index 0.425.
aPooled multiple imputation results.
bFor patients who have received treatment (those considering treatment have been taken into account in the modelling – no significant difference was found between patients considering
treatment and those who have received treatment (physical and daily living P-value 0.823).
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Despite this being the first study in Europe to examine the
relationship of supportive nursing care to patients’ unmet needs,
and the comparatively successful response to the survey, there are
strengths and weaknesses. In using the SCNS, we have examined
some need vs no need; in contrast, some studies have categorised
only moderate-to-severe need (Armes et al, 2009). We believe that
it is important for defining supportive care packages to consider
the range of unmet need since, if not supported, low need can
become moderate or even high need at a later stage. A further
strength of this study is that it is based on the more sensitive
measurement of unmet need, that is, assessing where help is needed,
rather than on quality-of-life, which in this population may not
consistently differentiate from the norm. A limitation with the SCNS
is that it has been validated for paper and electronic administration
via touch-screen computer (Boyes et al, 2002), but not currently for
on-line use. There is evidence from this study that the tool could
perform differently on psychological and physical and daily living
domains when administered on-line: the statistical modelling
indicated that men who completed the paper version were
significantly less likely to have unmet need in these domains than
men who completed the survey via the internet. This difference in
performance is unlikely to be the result of format selection bias, as
choice of format in this survey was not given at the point of
completion. However, there may have been some bias in the clinic
setting where paper was more easy to complete. Further research
would need to clarify this variation in the tool. A potential limitation
of this study is that the outcomes are based on reported measures of
nursing care, rather than on observed practice. However, the patient
perspective is important in that it tells us what patients value in
managing their care, and this is a crucial aspect to incorporate in
evaluating cancer services within a patient-centred care framework
(Velikova et al, 2002; Luckett et al, 2009).
A fundamental shift is required in survivorship care to improve
outcomes for men with prostate cancer, especially after treatment is
completed. Furthermore, more consistent provision of nurses across
the care pathway, with training to address sexual dysfunction and
psychological care, should be a priority for enhancing supportive care.
The provision of information, symptom management and long-term
side effects are areas in need of improvement. Recognition of specialist
nurses within cancer multidisciplinary teams is not consistent across
Europe and their inclusion should be essential in defining quality
prostate cancer care. As the population of men increases, so will the
need for monitoring and management. Whether after-care is received
from oncology, urology or primary care, it is important that all health-
care professionals recognise the extent of long-term consequences
experienced by cancer patients. Health-care services therefore need to
provide effective and targeted supportive care for men after prostate
cancer treatment to meet this growing population of survivors.
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